Abstract
Clinical applicability of rapid diagnostic test kit for SARS-CoV-2 antibodies was evaluated. The kit detected antibodies from day 9–56 of illness. IgG bands were observed up to 1: 1000 dilutions. The kit could detect 90.5% of IgG and 61.9% of IgM antibodies of mild febrile patients without pneumonia.
| Original language | English |
|---|---|
| Pages (from-to) | 97-100 |
| Number of pages | 4 |
| Journal | Journal of Microbiology, Immunology and Infection |
| Volume | 54 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antibody
- Point-of-care test
- Rapid diagnostic test
- SARS-CoV-2
- Titration
Fingerprint
Dive into the research topics of 'Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver